Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 Memorandum and Articles of Association
- 8.1 Opinion of Messina Madrid Law P.a. Regarding Certain U.S. Federal Income Taxation Matters
- 10.1 Deed of Rights Transfer, Strategic Partnership and Undertaking Between Sik-kee Au and Regencell Bioscience Limited Dated January 1, 2018
- 10.2 Amended and Restated Employment Agreement by and Between CEO Yat-gai Au and the Company Dated February 2, 2021
- 10.3 Supplemental Agreement of Deed of Rights Transfer, Strategic Partnership and Undertaking Between Sik-kee Au and Regencell Bioscience Limited Dated November 10, 2020
- 10.4 Loan Agreement Between Yat-gai Au and the Company Dated November 10, 2020
- 10.5 Employment Agreement Between DR. Yi-chung Chao and Regencell Bioscience Limited Dated July 15, 2019
- 10.6 Employment Agreement Between MR. James Wai Hong Chung and Regencell Bioscience Limited Dated July 6, 2019
- 10.7 Employment Agreement Between MR. Tien Hsiang Chau and Regencell Bioscience Limited Dated January 18, 2021
- 10.8 Loan Extension Agreement Between Yat-gai Au and the Company Dated February 2, 2021
- 10.9 Supplemental Loan Agreement by and Between Yat-gai Au and Regencell Bioscience Limited Dated March 18, 2021
- 10.10 Convertible Promissory Note Issued by Regencell Bioscience Holdings Limited Dated March 18, 2021
- 21.1 Subsidiaries
- 23.1 Consent of Friedman LLP
- 99.2 Consent of Evana Yee Wah Hui
- 99.3 Consent of Paul J. Niewiadomski
- 99.4 Consent of Cheung Ming Wong
- 99.5 Consent of Persistence Market Research
- 99.6 Consent of Fortune Business Insights
Associated filings
- 20 Jul 21 424B4 Prospectus supplement with pricing info
- 16 Jul 21 EFFECT Notice of effectiveness
- 8 Jul 21 FWP Free writing prospectus
- 30 Jun 21 FWP Free writing prospectus
- 23 Jun 21 F-1/A Registration statement (foreign) (amended)
- 11 Jun 21 F-1/A Registration statement (foreign) (amended)
- 26 Apr 21 F-1/A Registration statement (foreign) (amended)
-
22 Mar 21 F-1 Registration statement (foreign)
RGC similar filings
Filing view
External links
Exhibit 99.3
CONSENT OF PAUL J. NIEWIADOMSKI
Regencell Bioscience Holdings Ltd. (the “Company”) intends to file a Registration Statement on Form F-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement as a Director Nominee.
Dated: January 10, 2021
/s/ Paul J. Niewiadomski |
Paul J. Niewiadomski |